4.3 Article Proceedings Paper

Six-Day Randomized Safety Trial of Intravaginal Lime Juice

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAI.0b013e318186eae7

关键词

clinical trial; HIV; lime; microbicide; safety; vaginal

资金

  1. NCRR NIH HHS [M01RR000056] Funding Source: Medline

向作者/读者索取更多资源

Objectives: Nigerian women reportedly apply lime juice intravaginally to protect themselves against HIV In vitro data suggest that lime juice is virucidal, but only at cytotoxic concentrations. This is the first controlled, randomized safety trial of lime juice applied to the human vagina. Methods: Forty-seven women were randomized to apply water or lime juice (25%, 50%, or undiluted) intravaginally twice daily for two 6-day intervals, separated by a 3-week washout period. Product application also was randomized: during 1 interval, product was applied using a saturated tampon and in the other by douche. Vaginal pH, symptoms, signs of irritation observed via naked eye examination and colposcopy, microflora, and markers of inflammation in cervicovaginal lavages were evaluated after 1 hour and on days 3 and 7. Results: The largest reduction in pH was about one-half a pH unit, seen I hour after douching with 100% lime juice. We observed a dose-dependent pattern of symptoms and clinical and laboratory findings that were consistent with a compromised vaginal barrier function. Conclusions: The brief reduction in pH after vaginal lime juice application is unlikely to be virucidal in the presence of semen. Lime juice is unlikely to protect against HIV and may actually be harmful.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years

Melissa L. Gilliam, Jeffrey T. Jensen, David L. Eisenberg, Michael A. Thomas, Andrea Olariu, Mitchell D. Creinin

Summary: This study aimed to assess the relationship between parity and prior route of delivery to levonorgestrel 52 mg intrauterine system expulsion. Results showed that IUS expulsion occurs in less than 4% of users over the first 6 years of use, mostly during the first year, and is more likely among obese and parous women.

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

US referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: A case series

Namrata Mastey, Melissa C. Matulich, Suji Uhm, Courtney C. Baker, Juliana Melo, Melissa J. Chen, Mitchell D. Creinin

Summary: The study found that high-frequency point-of-care ultrasonography can effectively localize nonpalpable contraceptive implants, leading to successful in-office removal. This method has shown positive results in referral centers.

CONTRACEPTION (2021)

Letter Obstetrics & Gynecology

Ethinyl estradiol and levonorgestrel patch phase 3 data clarification

Mitchell D. Creinin

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results

Mitchell D. Creinin, Carolyn L. Westhoff, Celine Bouchard, Melissa J. Chen, Jeffrey T. Jensen, Andrew M. Kaunitz, Sharon L. Achilles, Jean-Michel Foidart, David F. Archer

Summary: This study assessed the efficacy, cycle control, and safety of an oral contraceptive containing E4 and DRSP, showing it to be an effective contraceptive with a predictable bleeding pattern and low adverse event rates.

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

Standardizing abortion research outcomes (STAR): Results from an international consensus development study

Katherine C. Whitehouse, Bianca M. Stifani, James M. N. Duffy, Caron R. Kim, Mitchell D. Creinin, Teresa DePineres, Beverly Winikoff, Kristina Gemzell-Danielsson, Jennifer Blum, Renee Bracey Sherman, Antonella F. Lavelanet, Dalia Brahmi, Daniel Grossman, Anand Tamang, Hailemichael Gebreselassie, Rodolfo Gomez Ponce de Leon, Bela Ganatra

Summary: By using consensus methods, a core outcome set for future abortion research has been developed, consisting of 15 outcomes that can standardize research, decrease trial heterogeneity, and enhance the quality of systematic reviews and clinical guidelines. Researchers are encouraged to select, collect, and report these core outcomes in future abortion trials, while journal editors should promote the reporting of core outcome sets.

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study

Suji Uhm, Namrata Mastey, Courtney C. Baker, Melissa J. Chen, Melissa C. Matulich, Melody Y. Hou, Juliana Melo, Susan F. Wilson, Mitchell D. Creinin

Summary: This study aimed to evaluate the impact of mifepristone given 18 to 24 hours before osmotic dilator placement on procedural outcomes. The results showed that mifepristone increased the initial cervical dilation but did not significantly affect the proportion of participants requiring additional dilators. The subjective perception of the procedure and complication rates were similar between the mifepristone and placebo groups.

CONTRACEPTION (2022)

Article Pharmacology & Pharmacy

Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion

Shelly Kaller, Natalie Morris, M. Antonia Biggs, C. Finley Baba, Sally Ra, Tina R. Raine-Bennett, Mitchell D. Creinin, Erin Berry, Elizabeth A. Micks, Karen R. Meckstroth, Sarah Averbach, Daniel Grossman

Summary: The study aimed to assess the feasibility of pharmacists dispensing mifepristone. Results showed that most pharmacists were willing to be trained, dispensed mifepristone with few challenges, were satisfied with the model, and had higher knowledge levels at follow-up.

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2021)

Article Health Care Sciences & Services

Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study

Alison Edelman, Agnes Hemon, Mitchell Creinin, Pascale Borensztein, Bruno Scherrer, Anna Glasier

Summary: This study aims to determine the cervical mucus characteristics following a 6-hour delayed pill intake or after one missed pill compared to typical daily use of norgestrel 75 mcg. The study has successfully enrolled 52 subjects and the analysis of the results is pending. The protocol was approved by a central review board and the study procedures were executed successfully.

JMIR RESEARCH PROTOCOLS (2021)

Editorial Material Obstetrics & Gynecology

Society of Family Planning Committee statement on IUD nomenclature Comment

Mitchell Creinin, Julia E. Kohn, Jennifer H. Tang, Tania Basu Serna

CONTRACEPTION (2022)

Article Obstetrics & Gynecology

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use

Mitchell D. Creinin, Courtney A. Schreiber, David K. Turok, Carrie Cwiak, Beatrice A. Chen, Andrea Olariu

Summary: This study aimed to evaluate the efficacy and safety of the levonorgestrel 52 mg intrauterine system during years 7 and 8 of use. The results showed that the system is highly effective and safe over an 8-year period of use, with low pregnancy rates and high user satisfaction.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Contraceptive plans before preoperative assessment and at procedure in surgical abortion patients

Britany R. Lundberg, Angel Tabuyo-Martin, Matthew D. Ponzini, Machelle D. Wilson, Mitchell D. Creinin

Summary: This study investigated changes in contraceptive method plans before, during, and after abortion among patients. The results showed that most patients received the method they initially identified at the telephone intake, especially those planning to use an IUD or implant. Undecided patients were open to discussing various options.

CONTRACEPTION (2022)

Editorial Material Obstetrics & Gynecology

Recommendations for standardization of bleeding data analyses in contraceptive studies Comment

Mitchell D. Creinin, Carolina Sales Vieira, Carolyn L. Westhoff, Diana J. A. Mansour

Summary: This study aims to address limitations in existing definitions of menstrual bleeding changes associated with contraceptive methods and proposes new recommendations for standardized bleeding data analyses. The study suggests three criteria for assessing bleeding outcomes: pattern, flow, and duration, and provides descriptors for each criterion based on the predictability of bleeding patterns. Standardizing outcomes allows for better comparison between studies and improved understanding of differences between contraceptive products for both clinicians and patients.

CONTRACEPTION (2022)

Letter Health Care Sciences & Services

Comparing IUC and Tubal Ligation

Mitchell D. Creinin, Melody Y. Hou

JOURNAL OF GENERAL INTERNAL MEDICINE (2023)

Article Obstetrics & Gynecology

Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation

Cassandra M. Gilbert, Melissa C. Matulich, Matthew D. Ponzini, Machelle D. Wilson, Mitchell D. Creinin

Summary: This study aimed to assess the correlation between quantitative blood loss (QBL) and clinically relevant outcomes or hemorrhage in dilation and evacuation (D&E) procedures. The findings showed that the majority of patients (75%) with clinically relevant bleeding outcomes had a QBL of 500mL or less. Therefore, the need for clinical interventions should be used to define hemorrhage in D&E procedures, rather than a specific amount of blood loss.

CONTRACEPTION (2023)

Letter Obstetrics & Gynecology

Extending use of levonorgestrel 52 mg intrauterine device to 8 years

Mitchell D. Creinin, Jeffrey T. Jensen

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

暂无数据